Foot And Mouth Disease Midscale Vaccine Production

SouthafricaTenders notice for Foot And Mouth Disease Midscale Vaccine Production. The reference ID of the tender is 61153912 and it is closing on 11 Feb 2022.

100% Secure Payments

Tender Details

  • Country: South Africa
  • Summary: Foot And Mouth Disease Midscale Vaccine Production
  • ZAT Ref No: 61153912
  • Deadline: 11 Feb 2022
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: -
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: ARC/29/12/2021
  • Purchaser's Detail :
  • Purchaser : AGRICULTURAL RESEARCH COUNCIL
    100 soutpan road - onderstepoort - pretoria - 0110
    Province : Gauteng
    Contact Person : ntokozo majola
    Tel : 012 529 479

    Email :majolan@arc.agric.za

  • Description :
  • Foot And Mouth Disease Midscale Vaccine Production
    Tender Type : Request for Bid(Open-Tender)
    Tender Status : Published
    Briefing Venue : OVR TAD Boardroom
    Compulsory Briefing Session : 2022-01-25T12:00:00
    Publishing Date : 2021-12-14T00:00:00
    Closing Date : 2022-02-11T11:00:00
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
SouthafricaTenders Features

SouthafricaTenders Features

Fresh and verified Tenders from Southafrica. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Southafrica in your email inbox.

  Chat with us